Using a mouse model of IL-2–anti-IL-2 antibody complex injection, the Bluestone group demonstrated that ILC2 cells were the primary IL-5–expressing cells arising following these injections, and that ablation of all IL-5+ cells prevented eosinophilia (Van Gool et al., 2014). Here, IL2 is linked to Increased total eosinophil count.